Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-10-10
2023-10-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs
NCT02515929
Functional Chewing Gum in Reduction of Gingival Inflammation
NCT03237624
Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment
NCT02536781
Delivery of Polyphenols in Gum as an Anti-Caries Agent
NCT05133557
The Use of Functional Confections in Promoting Oral Health
NCT01514552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be asked to refrain from eating, drinking, or using tobacco products, and vigorous exercise for 1 hour before the intervention period. Participants will also be asked to avoid chewing gum 48 hours before the intervention. Water is acceptable up until 10 minutes before sample collection. Participants will be given these instructions during the informed consent process, and will be sent a reminder email about study protocols at least 72 hours in advance of the study visit. If their second visit is 48 hours after their first, the investigators will remind them of these restrictions at the end of their first visit.
On the day of each intervention and sampling period, participants will be asked to visit the Bolling Laboratory at the Department of Food Science adhering to the dietary guidance described above. Participants with appliances or dentures will be asked to remove them during sampling periods. Then, participants will chew the intervention or control gum for a total of 60 minutes while providing chewed gum and saliva samples at specified intervals throughout this time. Participants will come back to the Bolling Laboratory at a later time, a minimum of 48 hours after the last sampling period, to chew the other gum in the same manner as the first sampling period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cranberry PLP
Chew the treatment chewing gum made with PLP at specific time intervals for a total of 60 minutes
polyphenol-lecithin precipitate (PLP)
Chewing gum made with material produced from patented technology to rapidly isolate polyphenols from fruit juice (PLP).
Cranberry Extract Control
Chew the control chewing gum made with Cranberry Extract at specific time intervals for a total of 60 minutes
control formulation
Chewing gum made with material produced from conventional technology (e.g cranberry extract).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
polyphenol-lecithin precipitate (PLP)
Chewing gum made with material produced from patented technology to rapidly isolate polyphenols from fruit juice (PLP).
control formulation
Chewing gum made with material produced from conventional technology (e.g cranberry extract).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing to avoid foods, beverages, tobacco products, and additional gum in the wash-in and wash-out periods
* willing to chew the intervention gum during the sampling periods
* willing to provide saliva and gum samples during the sampling periods
* willing to fill out post-visit surveys after their visits
Exclusion Criteria
* have less than 20 natural teeth and 8 natural posterior teeth (excluding third molars)
* have a salivary rate ≥ 0.3 mL/min as determined from an unstimulated salivary flow trial
* taking medications that contraindicates grapefruit juice consumption
* allergic to any intervention foods or ingredients (e.g. sunflower, soy, food colorants, berry ingredients, or any other component of the study gum)
* diagnosed with phenylketonuria (PKU), gross untreated caries, advanced gingivitis and periodontitis, and temporomandibular joint disorder
* participants who are pregnant or lactating
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wisconsin Alumni Research Foundation
UNKNOWN
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bradley Bolling, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Babcock Hall
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol Version 1/12/2023
Identifier Type: OTHER
Identifier Source: secondary_id
Food Science
Identifier Type: OTHER
Identifier Source: secondary_id
Discovery 2 Product
Identifier Type: OTHER
Identifier Source: secondary_id
2022-1703
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.